(Q45712822)

English

Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes

scientific article published on 17 April 2013

Statements

Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes (English)
Michele Malagola
Federica Cattina
Pierangelo Spedini

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit